LENZ Therapeutics, Inc. (LENZ)
3.64
-0.15
(-3.96%)
USD |
NASDAQ |
Oct 07, 10:53
LENZ Therapeutics Net Income (Quarterly) : -31.92M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -31.92M |
| March 31, 2026 | -41.49M |
| December 31, 2025 | -35.90M |
| September 30, 2025 | -16.70M |
| June 30, 2025 | -14.91M |
| March 31, 2025 | -14.62M |
| December 31, 2024 | -12.65M |
| September 30, 2024 | -10.22M |
| June 30, 2024 | -10.25M |
| March 31, 2024 | -16.65M |
| December 31, 2023 | -23.69M |
| September 30, 2023 | -18.88M |
| June 30, 2023 | -14.73M |
| Date | Value |
|---|---|
| March 31, 2023 | -12.67M |
| December 31, 2022 | -24.60M |
| September 30, 2022 | -24.68M |
| June 30, 2022 | -26.66M |
| March 31, 2022 | -26.14M |
| December 31, 2021 | -18.93M |
| September 30, 2021 | -14.59M |
| June 30, 2021 | -17.53M |
| March 31, 2021 | -19.71M |
| December 31, 2020 | -63.54M |
| September 30, 2020 | -3.384M |
| June 30, 2020 | -1.312M |
| March 31, 2020 | -0.141M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Impact BioMedical, Inc. | -0.70M |
| Enveric Biosciences, Inc. | -3.028M |
| Liquidia Corp. | 74.72M |
| Aquestive Therapeutics, Inc. | -22.86M |
| ANI Pharmaceuticals, Inc. | 23.00M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 5.486M |
| Total Expenses (Quarterly) | 37.40M |
| EPS Diluted (Quarterly) | -1.017 |
| Enterprise Value | -100.36M |
| Gross Profit Margin (Quarterly) | 94.90% |
| Profit Margin (Quarterly) | -581.8% |
| Earnings Yield | -112.1% |
| Normalized Earnings Yield | -112.12 |